DES in Patients at Low Risk for TVR: Is the Benefit Worth the Cost? (Part I)

In a recent article in Archives of Internal Medicine, researchers performed an analysis of current use of drug-eluting stents (DES) in patients at var...

To continue reading, please log in to the right or request an invitation.